Lars Karlberg

1.0k total citations
24 papers, 795 citations indexed

About

Lars Karlberg is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Nephrology. According to data from OpenAlex, Lars Karlberg has authored 24 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 5 papers in Nephrology. Recurrent topics in Lars Karlberg's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Pediatric Urology and Nephrology Studies (3 papers). Lars Karlberg is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Pediatric Urology and Nephrology Studies (3 papers). Lars Karlberg collaborates with scholars based in Sweden, Denmark and United States. Lars Karlberg's co-authors include Pär Stattin, Anders Bergh, Torvald Granfors, Lars Egevad, M. Wolgast, Jan‐Erik Damber, Bo Johan Norlén, G. Öjteg, Alicja Wolk and Swen‐Olof Andersson and has published in prestigious journals such as The Journal of Urology, European Urology and British Journal of Urology.

In The Last Decade

Lars Karlberg

24 papers receiving 757 citations

Peers

Lars Karlberg

PRM

RHEUM

NEPHR

UROLO

MB

Silvano Palazzo Italy

Thomas Jiborn Sweden

Satoshi Washino Japan

E. Becht Germany

A Sivula Finland

Christopher J. DiBlasio United States

Natascha Goemaere Netherlands

Hirotaka Asakura Japan

Chad A. Reichard United States

Takehiro Sejima Japan

Silvano Palazzo Italy

Lars Karlberg

376 ×0.9

PRM

54 ×0.4

RHEUM

104 ×0.8

NEPHR

58 ×0.5

UROLO

272 ×2.2

MB

Citations per year, relative to Lars Karlberg Lars Karlberg (= 1×) peers Silvano Palazzo

Countries citing papers authored by Lars Karlberg

Since Specialization

Citations

This map shows the geographic impact of Lars Karlberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Karlberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Karlberg more than expected).

Fields of papers citing papers by Lars Karlberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Karlberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Karlberg. The network helps show where Lars Karlberg may publish in the future.

Co-authorship network of co-authors of Lars Karlberg

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Karlberg. A scholar is included among the top collaborators of Lars Karlberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Karlberg. Lars Karlberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Josefsson, Andreas, Pernilla Wikström, Lars Egevad, et al.. (2012). Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance. Scandinavian Journal of Urology and Nephrology. 46(4). 247–257. 39 indexed citations

2.

Orsini, Nicola, Bahram Rashidkhani, Swen‐Olof Andersson, et al.. (2006). Long-Term Physical Activity and Lower Urinary Tract Symptoms in Men. The Journal of Urology. 176(6). 2546–2550. 25 indexed citations

3.

Josefsson, Andreas, Pernilla Wikström, Torvald Granfors, et al.. (2005). Tumor Size, Vascular Density and Proliferation as Prognostic Markers in GS 6 and GS 7 Prostate Tumors in Patients with Long Follow-Up and Non-Curative Treatment. European Urology. 48(4). 577–583. 33 indexed citations

4.

Andersson, Swen‐Olof, Bahram Rashidkhani, Lars Karlberg, Alicja Wolk, & Jan‐Erik Johansson. (2004). Prevalence of lower urinary tract symptoms in men aged 45–79 years: a population‐based study of 40 000 Swedish men. British Journal of Urology. 94(3). 327–331. 108 indexed citations

5.

Egevad, Lars, Torvald Granfors, Lars Karlberg, Anders Bergh, & Pär Stattin. (2002). Prognostic value of the Gleason score in prostate cancer. British Journal of Urology. 89(6). 538–542. 162 indexed citations

6.

Egevad, Lars, et al.. (2002). Percent Gleason Grade 4/5 as Prognostic Factor in Prostate Cancer Diagnosed at Transurethral Resection. The Journal of Urology. 509–513. 3 indexed citations

7.

Stattin, Pär, Jan‐Erik Damber, Lars Karlberg, & Anders Bergh. (1997). Cell Proliferation Assessed by Ki-67 Immunoreactivity on Formalin Fixed Tissues is a Predictive Factor for Survival in Prostate Cancer. The Journal of Urology. 219–222. 1 indexed citations

8.

Stattin, Pär, Jan‐Erik Damber, Lars Karlberg, & Anders Bergh. (1997). Cell Proliferation Assessed by Ki-67 Immunoreactivity on Formalin Fixed Tissues is a Predictive Factor for Survival in Prostate Cancer. The Journal of Urology. 157(1). 219–222. 73 indexed citations

9.

Stattin, Pär, Jan‐Erik Damber, Lars Karlberg, Hans Nordgren, & Anders Bergh. (1996). Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival. Urological Research. 24(5). 257–264. 38 indexed citations

10.

Stattin, Pär, Lars Karlberg, & Jan‐Erik Damber. (1996). Long-Term Outcome of Patients Treated for Hydrocele with the Sclerosant Agent Sodium Tetradecyl Sulphate. Scandinavian Journal of Urology and Nephrology. 30(2). 109–113. 19 indexed citations

11.

Nyberg, G., et al.. (1992). Kidneys transplanted in Göteborg, 1985 to 1990.. PubMed. 24(1). 326–7. 1 indexed citations

12.

Nordgren, Hans, Sten Nilsson, Pär Stattin, et al.. (1991). Modal DNA Values and Estramustine-Binding Protein (EMBP) as Prognostic Markers in Prostatic Cancer. Acta Oncologica. 30(2). 211–214. 8 indexed citations

13.

Nilsson, Sten, Hans Nordgren, Lars Karlberg, et al.. (1988). Expression of estramustine-binding protein (EMBP) and the proliferation-associated antigen Ki-67 in prostatic carcinomas.. PubMed. 110. 31–7. 13 indexed citations

14.

Wahlberg, J, Lars Karlberg, & A. Erik G. Persson. (1984). Total and regional renal blood flow during complete unilateral ureteral obstruction. Acta Physiologica Scandinavica. 121(2). 111–118. 9 indexed citations

15.

Karlberg, Lars, Bo Johan Norlén, G. Öjteg, & M. Wolgast. (1983). Impaired medullary circulation in postischemic acute renal failure. Acta Physiologica Scandinavica. 118(1). 11–17. 66 indexed citations

16.

Karlberg, Lars, Örjan Källskog, Bo Johan Norlén, & M. Wolgast. (1982). Postischemic renal failure. Intrarenal blood flow and functional characteristics in the recovery phase. Acta Physiologica Scandinavica. 115(1). 1–10. 24 indexed citations

17.

Karlberg, Lars, Örjan Källskog, Bo Johan Norlén, & M. Wolgast. (1982). Nephron Function in Postischemic Acute Renal Failure. Scandinavian Journal of Urology and Nephrology. 16(2). 167–172. 29 indexed citations

18.

Karlberg, Lars, Örjan Källskog, G. Öjteg, & M. Wolgast. (1982). Renal medullary blood flow studied with the 86‐Rb extraction method Methodological considerations. Acta Physiologica Scandinavica. 115(1). 11–18. 23 indexed citations

19.

Wolgast, M., et al.. (1982). Hemodynamic Alterations in Ischaemic Acute Renal Failure. The Nephron journals/Nephron journals. 31(4). 301–303. 29 indexed citations

20.

Karlberg, Lars. (1981). Postischemic renal failure : an experimental study in the rat. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact